Tuesday, March 17, 2026

Nuclear State Prepares Power Summit — What Comes Next?

North Korea's 9th Party Congress delegates arrive in Pyongyang, signaling imminent discussions on governance and future strategies.

LS Electric Brings a 2,900-sq-ft AI Factory to AW 2026: Predictive Maintenance Before Machines Break

LS Electric is set to showcase its AI-powered factory model at the AW 2026 expo, aiming to transform manufacturing and enhance productivity.

North Korea’s AI Suicide Drones Simulate Attacks on South Korean Military Targets

Kim Jong Un inspects AI-powered drones targeting U.S. and South Korean military equipment, showcasing advanced military capabilities.

Tag: Yuflyma

Celltrion’s Remsima SC: The Leading Autoimmune Drug with 68% Market Share in Europe

Celltrion's treatments for autoimmune diseases and cancer maintain strong market positions in Europe, bolstered by stable prescriptions and new products.

FDA Ruling Paves Way for Pharmacy Substitution of Yuflyma for Humira

Celltrion's Yuflyma receives FDA approval for interchangeability with Humira, boosting market confidence and distribution in the U.S.

Top News

- Our Sponsors Ad -

Follow us